Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

Victor G VogelThe University of Pittsburgh Cancer Institute, Magee-Womens Hospital, Pittsburgh, PA, USAAbstract: Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that has antiestrogenic effects on breast and endometrial tissue and estrogenic effects on bone, lipid metabolis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Victor G Vogel
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
raloxifene
osteoporosis
breast cancer risk reduction
Geriatrics
RC952-954.6
Acceso en línea:https://doaj.org/article/1e041e0247bf4427836baa6118c6155e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares